Pancrelipase Zenpep (pancrelipase) Delayed-release Capsules
Generic Name: pancrelipase zenpep (pancrelipase) delayed-release capsules
Dosage form: CAPSULE, DELAYED RELEASE. Active ingredients: PANCRELIPASE AMYLASE (14000 [USP'U]/1); PANCRELIPASE LIPASE (3000 [USP'U]/1); PANCRELIPASE PROTEASE (10000 [USP'U]/1). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: CAPSULE, DELAYED RELEASE. Active ingredients: PANCRELIPASE AMYLASE (14000 [USP'U]/1); PANCRELIPASE LIPASE (3000 [USP'U]/1); PANCRELIPASE PROTEASE (10000 [USP'U]/1). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as capsule, delayed release.
Related Medications
Apple Malus Sp.
apple malus sp.
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS, SUBCUTANEOUS. Active ingredients: APPLE (.1 g/mL). Category: BLA.
Queen Palm Coco Palm
queen palm coco palm
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: SYAGRUS ROMANZOFFIANA POLLEN (.05 g/mL). Category: BLA.
Zoledronic Acid
zoledronic acid
Zoledronic acid injection is a bisphosphonate indicated for treatment and prevention of postmenopausal osteoporosis, treatment to increase bone mass in men with osteoporosis, treatment and prevention of glucocorticoid-induced osteoporosis, and treatment of Paget's disease of bone in men and women. Optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use. It is administered as an intravenous infusion.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.